Radioactive Tracer Imaging of Autonomic Nervous System Synapses
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical imaging techniques, such as PET and SPECT, face challenges in accurately imaging autonomic nervous system (ANS) synaptic centers due to poor spatial resolution and limited clinical significance, particularly in diagnosing conditions like atrial fibrillation, where mIBG SPECT images have poor resolution compared to [C-11]hydroxyephedrine PET images but with unclear clinical significance.
Innovation Solution
A method involving the administration of a radioactive tracer that selectively binds to ANS synapses, allowing for 3-dimensional imaging and analysis of tracer distribution to identify high concentration regions, thereby imaging synaptic centers, and potentially guiding treatments like ablation of cardiac ganglionated plexuses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If mIBG SPECT imaging is used to image autonomic nervous system synaptic centers, then the imaging can be performed with available clinical equipment, but the spatial resolution is poor and diagnostic accuracy is limited
Solution Approach 1:
The patent changes the imaging parameters by switching from SPECT to PET modality, which provides superior spatial resolution for imaging autonomic nervous system synaptic centers. This parameter change resolves the contradiction by maintaining clinical applicability while significantly improving measurement precision and diagnostic accuracy
Solution Approach 2:
The patent uses radioactive tracers that selectively bind to autonomic nervous system synapses, creating a visual copy or map of synaptic center locations and activity. This copying approach enables precise localization and characterization of ANS activity patterns that would otherwise be invisible, resolving the spatial resolution limitation
2Device complexity
If conventional imaging techniques are used to image autonomic nervous system activity, then the imaging process is simple, but the clinical significance is limited and diagnostic value is unclear
Solution Approach 1:
The patent introduces radioactive tracers as intermediaries that selectively bind to autonomic nervous system synapses. These tracers act as mediators between the imaging system and the target tissue, providing specific information about synaptic center locations, densities, and activity patterns that have clear clinical significance for diagnosing conditions like atrial fibrillation
Solution Approach 2:
The patent segments the autonomic nervous system into discrete synaptic centers that can be individually identified, localized, and characterized. This segmentation approach transforms the complex ANS into distinguishable functional units, enabling precise diagnostic information to be extracted from the imaging data
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables precise imaging of ANS synaptic centers, improving diagnostic accuracy and treatment guidance for conditions associated with abnormal ANS activity, such as cardiac arrhythmias and other disorders, by providing detailed distribution and activity maps.
Implementation Method 1
administering a radioactive tracer which selectively binds to synapses of the autonomic nervous system; and measuring radioactive emission of the radioactive tracer
Implementation Method 2
measuring radioactive emission of the radioactive tracer to obtain data describing a distribution of the radioactive tracer in the body
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
A method is disclosed herein for imaging at least one autonomic nervous system synaptic center in a subject, as well as a method of diagnosing and/or monitoring a medical condition or disease associated with an autonomic nervous system, and a method of guiding a therapy of such a medical condition or disease. The methods comprise administering to the subject a radioactive tracer which selectively binds to autonomic nervous system synapses; measuring radioactive emission of the tracer to obtain data describing a distribution of the tracer in the body; and analyzing the data in order to identify at least one region exhibiting a high concentration of the tracer. Further disclosed herein are radioactive tracers, uses thereof, and an apparatus, for use in a method disclosed herein.